406939631	406939631	CD	B-NP	O
|	|	NNP	I-NP	O
WRMH	WRMH	NNP	I-NP	O
|	|	VBD	B-VP	O
52152218	52152218	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
565219	565219	CD	B-NP	O
|	|	CC	I-NP	O
10/9/2000	10/9/2000	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
R/O	R/O	NNP	I-NP	I-protein
MYOCARDIAL	MYOCARDIAL	NNP	I-NP	I-protein
INFARCTION	INFARCTION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/22/2000	1/22/2000	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/7/2000	6/7/2000	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
RULE	RULE	NN	B-NP	O
OUT	OUT	NN	I-NP	O
MYOCARDIAL	MYOCARDIAL	NN	I-NP	O
INFARCTION	INFARCTION	NN	I-NP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	O
LIST	LIST	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

HYPERTENSION	HYPERTENSION	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

NON-INSULIN	NON-INSULIN	NNP	B-NP	B-protein
DEPENDENT	DEPENDENT	NNP	I-NP	O
DIABETES	DIABETES	NNP	I-NP	O
MELLITUS	MELLITUS	NNP	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

HYPERCHOLESTEROLEMIA	HYPERCHOLESTEROLEMIA	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

PERIPHERAL	PERIPHERAL	NNP	B-NP	O
VASCULAR	VASCULAR	NNP	I-NP	O
DISEASE	DISEASE	NNP	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

PARKINSONISM	PARKINSONISM	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
72	72	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
non-insulin	non-insulin	JJ	B-NP	O
dependent	dependent	JJ	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
high	high	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	IN	B-PP	O
a	a	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	graft	VBG	B-VP	O
in	in	IN	B-PP	O
1992	1992	CD	B-NP	O
and	and	CC	O	O
catheterizations	catheterization	NNS	B-NP	O
in	in	IN	B-PP	O
1993	1993	CD	B-NP	O
and	and	CC	I-NP	O
1998	1998	CD	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
stable	stable	JJ	B-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
angina	angina	NN	I-NP	O
is	be	VBZ	B-VP	O
approximately	approximately	RB	B-ADVP	O
once	once	RB	O	O
per	per	IN	B-PP	O
week	week	NN	B-NP	O
,	,	,	O	O
always	always	RB	B-ADVP	O
responds	respond	VBZ	B-VP	O
to	to	TO	B-PP	O
one	one	CD	B-NP	O
sublingual	sublingual	JJ	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
usually	usually	RB	B-ADVP	O
diffuse	diffuse	JJ	B-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
front	front	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
and	and	CC	B-PP	O
across	across	IN	B-PP	O
her	her	PRP$	B-NP	O
back	back	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
she	she	PRP	B-NP	O
experienced	experience	VBD	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
which	which	WDT	B-NP	O
decreased	decrease	VBD	B-VP	O
after	after	IN	B-PP	O
one	one	CD	B-NP	O
sublingual	sublingual	JJ	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
lunch	lunch	NN	B-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
repeated	repeat	VBN	I-NP	O
episode	episode	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
relieved	relieve	VBN	I-VP	O
by	by	IN	B-PP	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
came	come	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Choharlbull	Choharlbull	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

Electrocardiogram	Electrocardiogram	NN	B-NP	O
there	there	RB	B-ADVP	O
showed	show	VBD	B-VP	O
lateral	lateral	JJ	B-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
recently	recently	RB	I-VP	O
undergoing	undergo	VBG	I-VP	O
a	a	DT	B-NP	O
work	work	NN	I-NP	O
up	up	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
40-50	40-50	CD	B-NP	O
pounds	pound	NNS	I-NP	O
over	over	IN	B-PP	O
only	only	RB	B-NP	O
a	a	DT	I-NP	O
couple	couple	NN	I-NP	O
of	of	IN	B-PP	O
months	month	NNS	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
ERCP	ERCP	NN	I-NP	B-DNA
in	in	IN	B-PP	O
5/12	5/12	CD	B-NP	O
showed	show	VBD	B-VP	O
narrowing	narrow	VBG	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
common	common	JJ	I-NP	O
bile	bile	NN	I-NP	O
duct	duct	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
narrow	narrow	NN	I-NP	O
was	be	VBD	B-VP	O
stented	stente	VBN	I-VP	O
and	and	CC	O	O
brushings	brushing	NNS	B-NP	O
were	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
.	.	.	O	O

These	These	DT	B-NP	O
brushings	brushing	NNS	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
for	for	IN	B-PP	O
cytology	cytology	NN	B-NP	O
and	and	CC	O	O
pathological	pathological	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	B-ADJP	O
diagnostic	diagnostic	JJ	I-ADJP	O
.	.	.	O	O

This	This	DT	B-NP	O
course	course	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
ERCP	ERCP	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
pancreatitis	pancreatitis	NN	B-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
in	in	IN	B-PP	O
7/16/98	7/16/98	CD	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
40-45	40-45	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
recent	recent	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
in	in	IN	B-PP	O
1998	1998	CD	B-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
SVG	SVG	NN	I-NP	O
to	to	TO	B-PP	O
OM1	OM1	NN	B-NP	O
graft	graft	NN	I-NP	O
patent	patent	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
SVG	SVG	NN	I-NP	O
to	to	TO	B-PP	O
RCA	RCA	NN	B-NP	O
graft	graft	NN	I-NP	O
patent	patent	NN	I-NP	O
,	,	,	O	O
LAD	LAD	NN	B-NP	B-protein
was	be	VBD	B-VP	O
totally	totally	RB	I-VP	O
occluded	occlude	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
RCA	RCA	NN	I-NP	B-protein
was	be	VBD	B-VP	O
40-50	40-50	CD	B-NP	O
%	%	NN	I-NP	O
occluded	occlude	VBD	B-VP	O
,	,	,	O	O
PDA	PDA	NN	B-NP	B-protein
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
ostial	ostial	JJ	I-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
rotabladed	rotablade	VBN	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
perforation	perforation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
short	short	JJ	I-NP	O
stay	stay	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	O
after	after	IN	B-PP	O
this	this	DT	B-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Dilaudid	Dilaudid	NN	B-NP	O
which	which	WDT	B-NP	O
makes	make	VBZ	B-VP	O
her	her	PRP	B-NP	O
dizzy	dizzy	JJ	B-ADJP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	graft	VBG	B-VP	O
1992	1992	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Two	Two	CD	B-NP	O
catheterizations	catheterization	NNS	I-NP	O
,	,	,	O	O
1993	1993	CD	B-NP	O
and	and	CC	I-NP	O
1998	1998	CD	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Non-insulin	Non-insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

High	High	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
fem/pop	fem/pop	NN	I-NP	O
and	and	CC	O	O
fem	fem	NN	B-NP	O
thrombectomy	thrombectomy	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Weight	Weight	NN	B-NP	O
loss	loss	NN	I-NP	O
with	with	IN	B-PP	O
constriction	constriction	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
common	common	JJ	I-NP	O
bile	bile	NN	I-NP	O
ducts	duct	NNS	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
ERCP	ERCP	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Pancreatitis	Pancreatitis	NN	B-NP	O
post	post	NN	I-NP	O
ERCP	ERCP	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Parkinsonism	Parkinsonism	NNP	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
atenolol	atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Imdur	Imdur	NN	B-NP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Metformin	Metformin	NN	B-NP	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
sinemet	sinemet	NN	B-NP	O
25/100	25/100	CD	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Zantac	Zantac	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Zoloft	Zoloft	NNP	B-NP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
drinking	drinking	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
smoking	smoking	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
widow	widow	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
quite	quite	RB	B-ADJP	O
active	active	JJ	I-ADJP	O
,	,	,	O	O
reports	report	NNS	B-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
goes	go	VBZ	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
lot	lot	NN	I-NP	O
of	of	IN	B-PP	O
parties	party	NNS	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
97.3	97.3	CD	I-NP	I-protein
,	,	,	O	O
pulse	pulse	NN	B-NP	O
66	66	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
144/60	144/60	CD	I-NP	O
,	,	,	O	O
breathing	breathe	VBG	B-VP	O
comfortably	comfortably	RB	B-ADVP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

GENERAL	GENERAL	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	O	O
,	,	,	O	O
comfortable	comfortable	JJ	B-NP	O
,	,	,	I-NP	O
friendly	friendly	JJ	I-NP	O
female	female	NN	I-NP	O
.	.	.	O	O

CHEST	CHEST	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Present	Present	JJ	B-NP	O
S1S2	S1S2	NN	I-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
II/VI	II/VI	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
heard	hear	VBD	B-VP	O
best	well	RBS	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Benign	Benign	NNP	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	O
exam	exam	NN	I-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
tremor	tremor	NN	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
baseline	baseline	NN	I-NP	O
per	per	IN	B-PP	O
patient	patient	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
otherwise	otherwise	RB	B-NP	O
nonfocal	nonfocal	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
SM-7	SM-7	NN	B-NP	B-protein
normal	normal	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
0.8	0.8	CD	B-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
5.11	5.11	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
36.4	36.4	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-protein
243	243	CD	B-NP	I-protein
,	,	,	O	O
CK	CK	NN	B-NP	B-protein
30	30	CD	I-NP	I-protein
,	,	,	O	O
Troponin-I	Troponin-I	NN	B-NP	O
0.02	0.02	CD	I-NP	O
,	,	,	O	O
lipase	lipase	NN	B-NP	O
276	276	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	B-protein
4.2	4.2	CD	I-NP	I-protein
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
rule	rule	NN	B-NP	O
out	out	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
MIBI	MIBI	NNP	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
exercise	exercise	NN	I-NP	O
she	she	PRP	B-NP	O
went	go	VBD	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
modified	modify	VBN	I-NP	O
Bruce	Bruce	NNP	I-NP	O
for	for	IN	B-PP	O
6	6	CD	B-NP	O
minutes	minute	NNS	I-NP	O
25	25	CD	B-NP	O
seconds	second	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
maximum	maximum	NN	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
150	150	CD	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
nondiagnostic	nondiagnostic	JJ	B-NP	O
ST	ST	NN	I-NP	O
changes	change	NNS	I-NP	O
during	during	IN	B-PP	O
exercise	exercise	NN	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
stopped	stop	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-VP	O
fatigue	fatigue	VB	I-VP	O
.	.	.	O	O

MIBI	MIBI	NN	B-NP	O
images	image	NNS	I-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
mixed	mix	VBN	I-NP	O
transmural	transmural	JJ	I-NP	O
and	and	CC	I-NP	O
nontransmural	nontransmural	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
involving	involve	VBG	B-VP	O
four	four	CD	B-NP	O
cardiac	cardiac	JJ	I-NP	O
segments	segment	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
lateral	lateral	JJ	I-NP	O
and	and	CC	I-NP	O
lateral	lateral	JJ	I-NP	O
wall	wall	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
moderate	moderate	JJ	B-NP	O
peri-infarct	peri-infarct	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
involving	involve	VBG	B-VP	O
additional	additional	JJ	B-NP	O
segments	segment	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
mild	mild	JJ	B-ADJP	O
to	to	TO	B-PP	O
moderate	moderate	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
involving	involve	VBG	B-VP	O
three	three	CD	B-NP	O
cardiac	cardiac	JJ	I-NP	O
segments	segment	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
lateral	lateral	JJ	I-NP	O
wall	wall	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
mild	mild	JJ	B-NP	O
anterior	anterior	JJ	I-NP	O
septal	septal	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
went	go	VBD	B-VP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
right	right	JJ	I-NP	O
dominant	dominant	JJ	I-NP	O
system	system	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descending	NN	I-NP	O
that	that	WDT	B-NP	O
had	have	VBD	B-VP	O
lesions	lesion	NNS	B-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Diagonal	Diagonal	NNP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
stented	stente	VBN	I-VP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
circ	circ	NN	I-NP	O
was	be	VBD	B-VP	O
occluded	occlude	VBN	I-VP	O
with	with	IN	B-PP	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
OM	OM	NN	I-NP	O
patent	patent	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
saphenous	saphenous	JJ	I-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
RCA	RCA	NN	I-NP	O
patent	patent	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
10	10	CD	I-NP	O
millimeter	millimeter	NN	I-NP	O
pseudoaneurysm	pseudoaneurysm	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
previous	previous	JJ	I-NP	O
PDA	PDA	NN	I-NP	O
rotablation	rotablation	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
thrombosed	thrombose	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
coil	coil	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
procedure	procedure	NN	I-NP	O
was	be	VBD	B-VP	O
accomplished	accomplish	VBN	I-VP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
mild	mild	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
reproducible	reproducible	JJ	B-ADJP	O
with	with	IN	B-PP	O
palpation	palpation	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	B-protein
anterior	anterior	JJ	I-NP	I-protein
ribs	rib	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
change	change	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Jamey	Jamey	NNP	I-NP	O
P	P	NNP	I-NP	O
Kahao	Kahao	NNP	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	NN	I-NP	O
;	;	:	O	O
atenolol	atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
bacitracin	bacitracin	NN	B-NP	O
topically	topically	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
omeprazole	omeprazole	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Sinemet	Sinemet	NNP	B-NP	O
25/100	25/100	CD	B-NP	O
p.o.	p.o.	NN	I-NP	O
1	1	CD	B-NP	O
tablet	tablet	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Zoloft	Zoloft	NNP	B-NP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Imdur	Imdur	NN	B-NP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Glucophage	Glucophage	NN	B-NP	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
prn	prn	NN	I-NP	O
,	,	,	O	O
take	take	VBP	B-VP	O
as	as	RB	B-VP	O
instructed	instruct	VBN	I-VP	O
;	;	:	O	O
lipid	lipid	NN	B-NP	O
lowering	lower	VBG	B-VP	O
study	study	NN	B-NP	O
medication	medication	NN	I-NP	O
as	as	IN	B-SBAR	O
instructed	instruct	VBN	B-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
STEVIE	STEVIE	NNP	B-NP	O
KEOGHAN	KEOGHAN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
FA89	FA89	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
AARON	AARON	NNP	B-NP	O
D.	D.	NNP	I-NP	O
CHANNEL	CHANNEL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
QT68	QT68	NNP	I-NP	O
QR022/0488	QR022/0488	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
70130	70130	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

LDCR061VZJ	LDCR061VZJ	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
10/17	10/17	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/18	1/18	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

MANUAL	MANUAL	NNP	B-NP	O
I.	I.	NNP	I-NP	O
DUSENBURY	DUSENBURY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
JZ2	JZ2	NNP	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

CURT	CURT	NNP	B-NP	O
NECESSARY	NECESSARY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
FN35	FN35	NNP	I-NP	O

